Acupuncture for the treatment of diarrheal-predominant irritable bowel syndrome: study protocol for a pilot randomized controlled trial (vol 22 ,page 253,year 2021)

被引：0
|
作者：
Qi, Ling-Yu [1 ]
Wang, Yu [1 ]
Wang, Li-Qiong [1 ]
She, Yan-Fen [2 ]
Shi, Guang-Xia [1 ]
Li, Ying [3 ]
Chi, Li-Li [4 ]
Wu, Bang-Qi [5 ]
Tu, Jian-Feng [1 ]
Lin, Ying [1 ]
Yu, Fang-Ting [1 ]
Yang, Jing-Wen [1 ]
Liu, Cun-Zhi [1 ]
机构：
[1] Beijing Univ Chinese Med, Int Acupuncture & Moxibust Innovat Inst, Sch Acupuncture Moxibust & Tuina, Beijing 100029, Peoples R China
[2] Hebei Univ Chinese Med, Sch Acupuncture Moxibust & Tuina, Shijiazhuang 050299, Peoples R China
[3] Chengdu Univ Chinese Med, Sch Grad, Chengdu 610075, Peoples R China
[4] Shandong Univ Tradit Chinese Med, Dept Spleen & Stomach, Affiliated Hosp, Jinan 250011, Peoples R China
[5] Tianjin Univ Tradit Chinese Med, Natl Acupuncture & Moxibust Clin Med Res Ctr, Teaching Hosp 1, Tianjin 300193, Peoples R China
来源：
TRIALS | 2023年 / 24卷 / 01期
关键词：
D O I：
10.1186/s13063-022-07016-y
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] MESALAZINE TREATMENT FOR INTESTINAL IMMUNE ACTIVATION IN PATIENTS WITH IRRITABLE BOWEL SYNDROME: A RANDOMIZED CONTROLLED PILOT TRIAL
    Barbara, G.
    Cremon, C.
    Gargano, L.
    De Giorgio, R.
    Cogliandro, R.
    Stanghellini, V.
    Corinaldesi, R.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 : S4 - S5
  • [22] Mesalazine treatment for intestinal immune activation in patient with irritable bowel syndrome: A randomized controlled pilot trial
    Barbara, Giovanni
    Cremon, Cesare
    Gargano, Luciana
    De Giorgio, Roberto
    Cogliandro, Rosanna
    Stanghellini, Vincenzo
    Corinaldesi, Roberto
    GASTROENTEROLOGY, 2008, 134 (04) : A546 - A546
  • [23] Electro-acupuncture for irritable bowel syndrome patients: study protocol for a single-blinded randomized sham-controlled clinical trial
    Zhong, Linda L. D.
    Lam, Tsz Fung
    Yang, Wei
    Zheng, Ya
    Lyu, Zipan
    Bian, Zhaoxiang
    TRIALS, 2021, 22 (01)
  • [24] Electro-acupuncture for irritable bowel syndrome patients: study protocol for a single-blinded randomized sham-controlled clinical trial
    Linda L. D. Zhong
    Tsz Fung Lam
    Wei Yang
    Ya Zheng
    Zipan Lyu
    Zhaoxiang Bian
    Trials, 22
  • [25] Effect of Samryungbaekchul-san Combined with Otilonium Bromide on Diarrhea-Predominant Irritable Bowel Syndrome: A Pilot Randomized Controlled Trial
    Lee, Jin-Hyun
    Kim, Joong Il
    Baeg, Myong Ki
    Sunwoo, Yun-Young
    Do, Kwangsun
    Lee, Jung-Han
    Kim, Hye-Jung
    Choi, Ja Sung
    Kim, Jayoung
    Seo, Chang-Seob
    Shin, Hyeun-Kyoo
    Ha, Hyekyung
    Park, Tae-Yong
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (10)
  • [26] A Novel Mobile App (Heali) for Disease Treatment in Participants With Irritable Bowel Syndrome: Randomized Controlled Pilot Trial
    Rafferty, Aaron J.
    Hall, Rick
    Johnston, Carol S.
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2021, 23 (03)
  • [27] Treatment of diarrhea-predominant irritable bowel syndrome with traditional Chinese herbal medicine: A randomized placebo-controlled trial
    Leung, Wai K.
    Wu, Justin C. Y.
    Liang, S. M.
    Chan, L. S.
    Chan, Francis K. L.
    Xie, He
    Fung, Sara S. L.
    Hui, Aric J.
    Wong, Vincent W. S.
    Che, Chun-Tao
    Sung, Joseph J. Y.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (07): : 1574 - 1580
  • [28] Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): study protocol for a randomised controlled trial
    Leighton, Matthew P.
    Lam, Ching
    Mehta, Samir
    Spiller, Robin C.
    TRIALS, 2013, 14
  • [29] The Chinese herbal formula Huoxiang Zhengqi for diarrhea-predominant irritable bowel syndrome (CHAIRS): a study protocol for a double-blinded randomized controlled trial
    Xiaohui Guo
    Meiling Xuan
    Huan Zheng
    Shumin Qin
    Haomeng Wu
    Shaogang Huang
    Zehuai Wen
    Trials, 22
  • [30] Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): study protocol for a randomised controlled trial
    Matthew P Leighton
    Ching Lam
    Samir Mehta
    Robin C Spiller
    Trials, 14
12345